Olga Martínez-Sáez

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Olga Martínez-Sáez
Sep 29, 2024, 15:48 | Blog
Elisabetta Bonzano: Dual HER2 inhibition, mechanisms of synergy
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared on X: "Dual HER2 inhibition:…
Sep 18, 2024, 23:03 | Insight
Aleix Prat: Dual HER2 inhibition in Breast Cancer
Aleix Prat shared a post on X about a recent paper by Adrienne Waks et…
Sep 15, 2024, 08:33 | Drugs
Paolo Tarantino: Some HER2+ tumors melt upon dual anti-HER2 Treatment
Paolo Tarantino shared on X: "Some HER2+ tumors melt upon dual anti-HER2 Treatment; others require…
Jul 22, 2024, 20:26 | Insight
How tumor biology impacts Patritumab deruxtecan's efficacy in early breast cancer
Sonia Guedan, Cancer Immunologist at Hospital Clinic Barcelona, posted on X: "Our colleague Aleix Prat's…
Jul 17, 2024, 12:35 | Insight
Aleix Prat: Our review article about HR+ breast cancer in young women
Aleix Prat, Head of the Medical Oncology Department at Hospital Clínic Barcelona, shared a post…
Jul 16, 2024, 23:13 | Blog
Benjamin Walbaum: Hormone receptor-positive early breast cancer in young women
Recently an article about: Hormone receptor-positive early breast cancer in young women: A comprehensive review…
Jul 15, 2024, 12:03 | Insight
Aleix Prat: Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer
Aleix Prat, Head of the Medical Oncology Department at Hospital Clínic Barcelona, shared a post…
Apr 28, 2024, 05:14 | Insight
Aleix Prat: Our new article about attitudes towards HER2DX in Spain
Aleix Prat, Director of the Cancer Institute at Hospital Clinic of Barcelona, shared on X/Twitter:…
All: 8 Posts: 1 - 100
Special Coverage